Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Polycystic Ovary Syndrome × Letrozole × Clear all

Phase

Phase NA 15 Phase 3 9 Phase 4 5 Phase 1 3 Phase 2/3 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 143 Endometrial Neoplasms 13 Ovarian Neoplasms 12 Fallopian Tube Neoplasms 5 Recurrence 4 Neoplasms 4 Neoplasm Metastasis 4 Carcinoma, Intraductal, Noninfiltrating 4 Breast Cancer Metastatic 3 Triple Negative Breast Neoplasms 2 Prostatic Neoplasms 2 Leiomyosarcoma 2 Carcinoma, Lobular 2 Breast Diseases 2 Advanced Breast Cancer 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Polycystic Ovary Syndrome 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Pain 1 Osteoporosis 1 Neoplastic Cells, Circulating 1 Neoadjuvant Operable Breast Cancer 1 Multiple Endocrine Neoplasia Type 1 1 Medullary cystic kidney disease 1 1 Lymphangioleiomyomatosis 1

Interventions

Metformin 9 Clomiphene 6 maltodextrin 2 artenimol 2 Sugars 2 Spironolactone 2 Pioglitazone 2 Orlistat 2 Inositol 2 Contraceptives, Oral 2 Cholecalciferol 2 salicylsalicylic acid 1 licogliflozin 1 follitropin alfa 1 elagolix 1 Vitamin E 1 Vitamin D 1 Thioctic Acid 1 Tablets 1 Sodium Salicylate 1 Resveratrol 1 Pentoxifylline 1 Ovulation Induction 1 Linseed Oil 1 Leuprolide 1 Letrozole 1 Inulin 1 Interleukin 1 Receptor Antagonist Protein 1 Gonadotropins 1 Folic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02551367 2015-09-16

LVCCFOROI

Ain Shams Maternity Hospital

Phase 2 Unknown

Anovulation, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡